Collecting samples to study heart disease
Health eHeart BioBank
University of California, San Francisco · NCT06976502
This study is collecting blood and tissue samples from participants to see if they can find new ways to diagnose and treat heart disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco (other) |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT06976502 on ClinicalTrials.gov |
What this trial studies
The Health eHeart BioBank aims to gather and store biological specimens such as blood, DNA, and tissue from participants to enhance understanding of heart disease. This observational study is conducted at the University of California, San Francisco (UCSF) and focuses on identifying molecular and genetic markers associated with cardiovascular conditions. By analyzing these samples, researchers hope to develop new diagnostic tools and treatments that can improve the detection and management of heart disease.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18 and older who are established patients at UCSF, family members of patients with cardiovascular disease, or patients without cardiovascular disease.
Not a fit: Patients who are unwilling to consent to biospecimen collection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to advancements in the early detection and treatment of heart disease.
How similar studies have performed: Other studies focusing on biospecimen collection for cardiovascular research have shown promise in identifying key markers and improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years or older. And at least one of the following: * Established patient seen at UCSF and/or is a current participant in a clinical study that utilizes the HeH BioBank for biospecimen collection. * Family member of a patient with cardiovascular disease. * Patient with no cardiovascular disease. Exclusion Criteria: * Unwilling to consent to biospecimen collection through the HeH BioBank.
Where this trial is running
San Francisco, California
- University of California, San Francisco — San Francisco, California, United States (RECRUITING)
Study contacts
- Principal investigator: Jeffrey E Olgin, MD — University of California, San Francisco
- Study coordinator: Ashley D Cristal, MD
- Email: ashley.cristal@ucsf.edu
- Phone: 415-514-1169
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Diseases, Cardiac Diseases, Vascular Diseases, Cardiovascular Diseases, Heart Disease, Cardiovascular Disease, Cardiology